-
1
-
-
0346727127
-
Protein degradation and protection against misfolded or damaged proteins
-
Goldberg, A.L. Protein degradation and protection against misfolded or damaged proteins. Nature, 2003, 426, 895-899.
-
(2003)
Nature
, vol.426
, pp. 895-899
-
-
Goldberg, A.L.1
-
2
-
-
5344234076
-
The ubiquitin-mediated protein degradation pathway in cancer: Therapeutic implications
-
Burger, A.M.; Seth, A.K. The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications. Eur J Cancer, 2004, 40, 2217-2229.
-
(2004)
Eur J Cancer
, vol.40
, pp. 2217-2229
-
-
Burger, A.M.1
Seth, A.K.2
-
3
-
-
83455238007
-
Targeting the ubiquitinproteasome pathway: An emerging concept in cancer therapy
-
Frezza, M.; Schmitt, S.; Dou, Q.P. Targeting the ubiquitinproteasome pathway: an emerging concept in cancer therapy. Current topics in medicinal chemistry, 2011, 11, 2888-2905.
-
(2011)
Current Topics In Medicinal Chemistry
, vol.11
, pp. 2888-2905
-
-
Frezza, M.1
Schmitt, S.2
Dou, Q.P.3
-
4
-
-
50449091498
-
Advances in and applications of proteasome inhibitors
-
Moore, B.S.; Eustaquio, A.S.; McGlinchey, R.P. Advances in and applications of proteasome inhibitors. Current opinion in chemical biology, 2008, 12, 434-440.
-
(2008)
Current Opinion In Chemical Biology
, vol.12
, pp. 434-440
-
-
Moore, B.S.1
Eustaquio, A.S.2
McGlinchey, R.P.3
-
5
-
-
79951702955
-
Q, P.D. Bortezomib as the first proteasome inhibitor anticancer drug: Current status and future perspectives
-
Chen, D.; Frezza, M.; Schmitt, S.; Kanwar, J.; Q, P.D. Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives. Current cancer drug targets, 2011, 11, 239-253.
-
(2011)
Current Cancer Drug Targets
, vol.11
, pp. 239-253
-
-
Chen, D.1
Frezza, M.2
Schmitt, S.3
Kanwar, J.4
-
7
-
-
0031982133
-
Structure and assembly of the 20S proteasome
-
Gerards, W.L.; de Jong, W.W.; Boelens, W.; Bloemendal, H. Structure and assembly of the 20S proteasome. Cellular and molecular life sciences: CMLS, 1998, 54, 253-262.
-
(1998)
Cellular and Molecular Life Sciences: CMLS
, vol.54
, pp. 253-262
-
-
Gerards, W.L.1
de Jong, W.W.2
Boelens, W.3
Bloemendal, H.4
-
8
-
-
61449206184
-
The persisting challenge of selective and specific proteasome inhibition
-
Groll, M.; Huber, R.; Moroder, L. The persisting challenge of selective and specific proteasome inhibition. Journal of peptide science: an official publication of the European Peptide Society, 2009, 15, 58-66.
-
(2009)
Journal of Peptide Science: An Official Publication of the European Peptide Society
, vol.15
, pp. 58-66
-
-
Groll, M.1
Huber, R.2
Moroder, L.3
-
9
-
-
0024285837
-
Identity of the 19S 'prosome' particle with the large multifunctional protease complex of mammalian cells (the proteasome)
-
Arrigo, A.P.; Tanaka, K.; Goldberg, A.L.; Welch, W.J. Identity of the 19S 'prosome' particle with the large multifunctional protease complex of mammalian cells (the proteasome). Nature, 1988, 331, 192-194.
-
(1988)
Nature
, vol.331
, pp. 192-194
-
-
Arrigo, A.P.1
Tanaka, K.2
Goldberg, A.L.3
Welch, W.J.4
-
10
-
-
63649086487
-
Targeting the ubiquitin system in cancer therapy
-
Hoeller, D.; Dikic, I. Targeting the ubiquitin system in cancer therapy. Nature, 2009, 458, 438-444.
-
(2009)
Nature
, vol.458
, pp. 438-444
-
-
Hoeller, D.1
Dikic, I.2
-
11
-
-
0024585225
-
The multicatalytic proteinase of mammalian cells
-
Rivett, A.J. The multicatalytic proteinase of mammalian cells. Archives of biochemistry and biophysics, 1989, 268, 1-8.
-
(1989)
Archives of Biochemistry and Biophysics
, vol.268
, pp. 1-8
-
-
Rivett, A.J.1
-
12
-
-
12744260116
-
Use of proteasome inhibition in the treatment of lung cancer
-
Schenkein, D.P. Use of proteasome inhibition in the treatment of lung cancer. Clinical lung cancer, 2004, 6 Suppl 2, S89-S96.
-
(2004)
Clinical Lung Cancer
, vol.6
, Issue.SUPPL. 2
-
-
Schenkein, D.P.1
-
13
-
-
0036469858
-
Development and evaluation of a sandwich ELISA for quantification of the 20S proteasome in human plasma
-
Dutaud, D.; Aubry, L.; Henry, L.; Levieux, D.; Hendil, K.B.; Kuehn, L.; Bureau, J.P.; Ouali, A. Development and evaluation of a sandwich ELISA for quantification of the 20S proteasome in human plasma. Journal of immunological methods, 2002, 260, 183-193.
-
(2002)
Journal of Immunological Methods
, vol.260
, pp. 183-193
-
-
Dutaud, D.1
Aubry, L.2
Henry, L.3
Levieux, D.4
Hendil, K.B.5
Kuehn, L.6
Bureau, J.P.7
Ouali, A.8
-
14
-
-
0036083396
-
The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction
-
Glickman, M.H.; Ciechanover, A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiological reviews, 2002, 82, 373-428.
-
(2002)
Physiological Reviews
, vol.82
, pp. 373-428
-
-
Glickman, M.H.1
Ciechanover, A.2
-
15
-
-
0037852202
-
The proteasome: Structure, function, and role in the cell
-
Adams, J. The proteasome: structure, function, and role in the cell. Cancer Treat Rev, 2003, 29 Suppl 1, 3-9.
-
(2003)
Cancer Treat Rev
, vol.29
, Issue.SUPPL. 1
, pp. 3-9
-
-
Adams, J.1
-
16
-
-
0036395180
-
Ubiquitin-dependent proteolysis: Its role in human diseases and the design of therapeutic strategies
-
Sakamoto, K.M. Ubiquitin-dependent proteolysis: its role in human diseases and the design of therapeutic strategies. Molecular genetics and metabolism, 2002, 77, 44-56.
-
(2002)
Molecular Genetics and Metabolism
, vol.77
, pp. 44-56
-
-
Sakamoto, K.M.1
-
17
-
-
0041805434
-
Gene expression profiling of ductal carcinomas in situ and invasive breast tumors
-
Seth, A.; Kitching, R.; Landberg, G.; Xu, J.; Zubovits, J.; Burger, A.M. Gene expression profiling of ductal carcinomas in situ and invasive breast tumors. Anticancer research, 2003, 23, 2043-2051.
-
(2003)
Anticancer Research
, vol.23
, pp. 2043-2051
-
-
Seth, A.1
Kitching, R.2
Landberg, G.3
Xu, J.4
Zubovits, J.5
Burger, A.M.6
-
18
-
-
67649658188
-
Controlling Platinum, Ruthenium and Osmium Reactivity for Anticancer Drug Design
-
Bruijnincx, P.C.; Sadler, P.J. Controlling Platinum, Ruthenium and Osmium Reactivity for Anticancer Drug Design. Advances in inorganic chemistry, 2009, 61, 1-62.
-
(2009)
Advances In Inorganic Chemistry
, vol.61
, pp. 1-62
-
-
Bruijnincx, P.C.1
Sadler, P.J.2
-
19
-
-
0001384447
-
Metals in Medicine
-
Guo, Z.; Sadler, P. Metals in Medicine. Angew Chem Int Ed, 1999, 38, 1512-1531.
-
(1999)
Angew Chem Int Ed
, vol.38
, pp. 1512-1531
-
-
Guo, Z.1
Sadler, P.2
-
20
-
-
33750295521
-
Classical and Non-Classical Ruthenium-Based Anticancer Drugs: Towards Targeted Chemotherapy
-
Ang, W.; Dyson, P. Classical and Non-Classical Ruthenium-Based Anticancer Drugs: Towards Targeted Chemotherapy. Eur J Inorg Chem, 2006, 4003-4018.
-
(2006)
Eur J Inorg Chem
, pp. 4003-4018
-
-
Ang, W.1
Dyson, P.2
-
21
-
-
33845772944
-
Diversity in guanine-selective DNA binding modes for an organometallic ruthenium arene complex
-
Liu, H.K.; Berners-Price, S.J.; Wang, F.; Parkinson, J.A.; Xu, J.; Bella, J.; Sadler, P.J. Diversity in guanine-selective DNA binding modes for an organometallic ruthenium arene complex. Angew Chem Int Ed Engl, 2006, 45, 8153-8156.
-
(2006)
Angew Chem Int Ed Engl
, vol.45
, pp. 8153-8156
-
-
Liu, H.K.1
Berners-Price, S.J.2
Wang, F.3
Parkinson, J.A.4
Xu, J.5
Bella, J.6
Sadler, P.J.7
-
22
-
-
33750969384
-
Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands
-
Habtemariam, A.; Melchart, M.; Fernandez, R.; Parsons, S.; Oswald, I.D.; Parkin, A.; Fabbiani, F.P.; Davidson, J.E.; Dawson, A.; Aird, R.E.; Jodrell, D.I.; Sadler, P.J. Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands. Journal of medicinal chemistry, 2006, 49, 6858-6868.
-
(2006)
Journal of Medicinal Chemistry
, vol.49
, pp. 6858-6868
-
-
Habtemariam, A.1
Melchart, M.2
Fernandez, R.3
Parsons, S.4
Oswald, I.D.5
Parkin, A.6
Fabbiani, F.P.7
Davidson, J.E.8
Dawson, A.9
Aird, R.E.10
Jodrell, D.I.11
Sadler, P.J.12
-
23
-
-
12844288905
-
Novel approaches to the treatment of cocaine addiction
-
Sofuoglu, M.; Kosten, T.R. Novel approaches to the treatment of cocaine addiction. CNS drugs, 2005, 19, 13-25.
-
(2005)
CNS Drugs
, vol.19
, pp. 13-25
-
-
Sofuoglu, M.1
Kosten, T.R.2
-
24
-
-
17744366583
-
Effects of pyrrolidine dithiocarbamate, an NF-kappaB inhibitor, on cytokine expression and ocular inflammation in experimental autoimmune anterior uveitis
-
Fang, I.M.; Yang, C.H.; Lin, C.P.; Yang, C.M.; Chen, M.S. Effects of pyrrolidine dithiocarbamate, an NF-kappaB inhibitor, on cytokine expression and ocular inflammation in experimental autoimmune anterior uveitis. Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics, 2005, 21, 95-106.
-
(2005)
Journal of Ocular Pharmacology and Therapeutics: The Official Journal of the Association For Ocular Pharmacology and Therapeutics
, vol.21
, pp. 95-106
-
-
Fang, I.M.1
Yang, C.H.2
Lin, C.P.3
Yang, C.M.4
Chen, M.S.5
-
25
-
-
20744441360
-
Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway
-
Si, X.; McManus, B.M.; Zhang, J.; Yuan, J.; Cheung, C.; Esfandiarei, M.; Suarez, A.; Morgan, A.; Luo, H. Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway. Journal of virology, 2005, 79, 8014-8023.
-
(2005)
Journal of Virology
, vol.79
, pp. 8014-8023
-
-
Si, X.1
McManus, B.M.2
Zhang, J.3
Yuan, J.4
Cheung, C.5
Esfandiarei, M.6
Suarez, A.7
Morgan, A.8
Luo, H.9
-
26
-
-
0033178142
-
Proteasome inhibitors as potential novel anticancer agents
-
Dou, Q.P.; Li, B. Proteasome inhibitors as potential novel anticancer agents. Drug Resist Updat, 1999, 2, 215-223.
-
(1999)
Drug Resist Updat
, vol.2
, pp. 215-223
-
-
Dou, Q.P.1
Li, B.2
-
27
-
-
0036240701
-
The proteasome: A novel target for cancer chemotherapy
-
Almond, J.B.; Cohen, G.M. The proteasome: a novel target for cancer chemotherapy. Leukemia, 2002, 16, 433-443.
-
(2002)
Leukemia
, vol.16
, pp. 433-443
-
-
Almond, J.B.1
Cohen, G.M.2
-
28
-
-
0038743111
-
The role of the ubiquitinationproteasome pathway in breast cancer: Applying drugs that affect the ubiquitin-proteasome pathway to the therapy of breast cancer
-
Orlowski, R.Z.; Dees, E.C. The role of the ubiquitinationproteasome pathway in breast cancer: applying drugs that affect the ubiquitin-proteasome pathway to the therapy of breast cancer. Breast Cancer Res, 2003, 5, 1-7.
-
(2003)
Breast Cancer Res
, vol.5
, pp. 1-7
-
-
Orlowski, R.Z.1
Dees, E.C.2
-
29
-
-
0032429122
-
Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts
-
An, B.; Goldfarb, R.H.; Siman, R.; Dou, Q.P. Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts. Cell death and differentiation, 1998, 5, 1062-1075.
-
(1998)
Cell Death and Differentiation
, vol.5
, pp. 1062-1075
-
-
An, B.1
Goldfarb, R.H.2
Siman, R.3
Dou, Q.P.4
-
30
-
-
33751275548
-
A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts
-
Milacic, V.; Chen, D.; Ronconi, L.; Landis-Piwowar, K.R.; Fregona, D.; Dou, Q.P. A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts. Cancer research, 2006, 66, 10478-10486.
-
(2006)
Cancer Research
, vol.66
, pp. 10478-10486
-
-
Milacic, V.1
Chen, D.2
Ronconi, L.3
Landis-Piwowar, K.R.4
Fregona, D.5
Dou, Q.P.6
-
31
-
-
48649110541
-
Pyrrolidine dithiocarbamate-zinc(II) and -copper(II) complexes induce apoptosis in tumor cells by inhibiting the proteasomal activity
-
Milacic, V.; Chen, D.; Giovagnini, L.; Diez, A.; Fregona, D.; Dou, Q.P. Pyrrolidine dithiocarbamate-zinc(II) and -copper(II) complexes induce apoptosis in tumor cells by inhibiting the proteasomal activity. Toxicology and applied pharmacology, 2008, 231, 24-33.
-
(2008)
Toxicology and Applied Pharmacology
, vol.231
, pp. 24-33
-
-
Milacic, V.1
Chen, D.2
Giovagnini, L.3
Diez, A.4
Fregona, D.5
Dou, Q.P.6
-
32
-
-
28844443296
-
Analysis of cytotoxicities of platinum compounds
-
Goodisman, J.; Hagrman, D.; Tacka, K.A.; Souid, A.K. Analysis of cytotoxicities of platinum compounds. Cancer Chemother Pharmacol, 2006, 57, 257-267.
-
(2006)
Cancer Chemother Pharmacol
, vol.57
, pp. 257-267
-
-
Goodisman, J.1
Hagrman, D.2
Tacka, K.A.3
Souid, A.K.4
-
33
-
-
77953759573
-
Fresh platinum complexes with promising antitumor activity
-
Wang, X. Fresh platinum complexes with promising antitumor activity. Anticancer Agents Med Chem, 2010, 10, 396-411.
-
(2010)
Anticancer Agents Med Chem
, vol.10
, pp. 396-411
-
-
Wang, X.1
-
34
-
-
38349047708
-
Metal-Ligand Exchange Kinetics in Platinum and Ruthenium Complexes
-
Reedijk, J. Metal-Ligand Exchange Kinetics in Platinum and Ruthenium Complexes. Platinum Met Rev, 2008, 52, 2-11.
-
(2008)
Platinum Met Rev
, vol.52
, pp. 2-11
-
-
Reedijk, J.1
-
36
-
-
3042656649
-
Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity
-
Marzano, C.; Bettio, F.; Baccichetti, F.; Trevisan, A.; Giovagnini, L.; Fregona, D. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity. Chemico-biological interactions, 2004, 148, 37-48.
-
(2004)
Chemico-biological Interactions
, vol.148
, pp. 37-48
-
-
Marzano, C.1
Bettio, F.2
Baccichetti, F.3
Trevisan, A.4
Giovagnini, L.5
Fregona, D.6
-
37
-
-
71549140059
-
The Midas touch in cancer chemotherapy: From platinum- to gold-dithiocarbamato complexes
-
Ronconi, L.; Fregona, D. The Midas touch in cancer chemotherapy: from platinum- to gold-dithiocarbamato complexes. Dalton Trans, 2009, 10670-10680.
-
(2009)
Dalton Trans
, pp. 10670-10680
-
-
Ronconi, L.1
Fregona, D.2
-
38
-
-
0002624111
-
Medical uses of gold compounds: Past, present and future
-
Fricker, S. Medical uses of gold compounds: past, present and future. Gold Bulletin, 1996, 29, 53-60.
-
(1996)
Gold Bulletin
, vol.29
, pp. 53-60
-
-
Fricker, S.1
-
39
-
-
0022630003
-
Correlation of the in vitro cytotoxic and in vivo antitumor activities of gold(I) coordination complexes
-
Mirabelli, C.K.; Johnson, R.K.; Hill, D.T.; Faucette, L.F.; Girard, G.R.; Kuo, G.Y.; Sung, C.M.; Crooke, S.T. Correlation of the in vitro cytotoxic and in vivo antitumor activities of gold(I) coordination complexes. J. Med. Chem., 1986, 29, 218-223.
-
(1986)
J. Med. Chem
, vol.29
, pp. 218-223
-
-
Mirabelli, C.K.1
Johnson, R.K.2
Hill, D.T.3
Faucette, L.F.4
Girard, G.R.5
Kuo, G.Y.6
Sung, C.M.7
Crooke, S.T.8
-
40
-
-
35748937356
-
Gold complexes as prospective metal-based anticancer drugs
-
Milacic, V.; Fregona, D.; Dou, Q.P. Gold complexes as prospective metal-based anticancer drugs. Histology and histopathology, 2008, 23, 101-108.
-
(2008)
Histology and Histopathology
, vol.23
, pp. 101-108
-
-
Milacic, V.1
Fregona, D.2
Dou, Q.P.3
-
41
-
-
0032734670
-
A Screening Strategy for Metal Antitumor Agents as Exemplified by Gold(III) Complexes
-
Fricker, S.P. A Screening Strategy for Metal Antitumor Agents as Exemplified by Gold(III) Complexes. Metal-based drugs, 1999, 6, 291-300.
-
(1999)
Metal-based Drugs
, vol.6
, pp. 291-300
-
-
Fricker, S.P.1
-
42
-
-
33644855554
-
Gold(III) dithiocarbamate derivatives for the treatment of cancer: Solution chemistry, DNA binding, and hemolytic properties
-
Ronconi, L.; Marzano, C.; Zanello, P.; Corsini, M.; Miolo, G.; Macca, C.; Trevisan, A.; Fregona, D. Gold(III) dithiocarbamate derivatives for the treatment of cancer: solution chemistry, DNA binding, and hemolytic properties. Journal of medicinal chemistry, 2006, 49, 1648-1657.
-
(2006)
Journal of Medicinal Chemistry
, vol.49
, pp. 1648-1657
-
-
Ronconi, L.1
Marzano, C.2
Zanello, P.3
Corsini, M.4
Miolo, G.5
Macca, C.6
Trevisan, A.7
Fregona, D.8
-
44
-
-
15944361817
-
Gold dithiocarbamate derivatives as potential antineoplastic agents: Design, spectroscopic properties, and in vitro antitumor activity
-
Ronconi, L.; Giovagnini, L.; Marzano, C.; Bettio, F.; Graziani, R.; Pilloni, G.; Fregona, D. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity. Inorganic chemistry, 2005, 44, 1867-1881.
-
(2005)
Inorganic Chemistry
, vol.44
, pp. 1867-1881
-
-
Ronconi, L.1
Giovagnini, L.2
Marzano, C.3
Bettio, F.4
Graziani, R.5
Pilloni, G.6
Fregona, D.7
-
45
-
-
0022542073
-
Effect of diethyldithiocarbamate on cis-diamminedichloroplatinum(II)-induced cytotoxicity, DNA cross-linking, and gamma-glutamyl transpeptidase inhibition
-
Bodenner, D.L.; Dedon, P.C.; Keng, P.C.; Borch, R.F. Effect of diethyldithiocarbamate on cis-diamminedichloroplatinum(II)-induced cytotoxicity, DNA cross-linking, and gamma-glutamyl transpeptidase inhibition. Cancer research, 1986, 46, 2745-2750.
-
(1986)
Cancer Research
, vol.46
, pp. 2745-2750
-
-
Bodenner, D.L.1
Dedon, P.C.2
Keng, P.C.3
Borch, R.F.4
-
46
-
-
0029585833
-
Solution structure of a cisplatin-induced DNA interstrand crosslink
-
Huang, H.; Zhu, L.; Reid, B.R.; Drobny, G.P.; Hopkins, P.B. Solution structure of a cisplatin-induced DNA interstrand crosslink. Science, 1995, 270, 1842-1845.
-
(1995)
Science
, vol.270
, pp. 1842-1845
-
-
Huang, H.1
Zhu, L.2
Reid, B.R.3
Drobny, G.P.4
Hopkins, P.B.5
-
47
-
-
73849121224
-
Inhibition of tumor proteasome activity by gold-dithiocarbamato complexes via both redox-dependent and - independent processes
-
Zhang, X.; Frezza, M.; Milacic, V.; Ronconi, L.; Fan, Y.; Bi, C.; Fregona, D.; Dou, Q.P. Inhibition of tumor proteasome activity by gold-dithiocarbamato complexes via both redox-dependent and - independent processes. Journal of cellular biochemistry, 2010, 109, 162-172.
-
(2010)
Journal of Cellular Biochemistry
, vol.109
, pp. 162-172
-
-
Zhang, X.1
Frezza, M.2
Milacic, V.3
Ronconi, L.4
Fan, Y.5
Bi, C.6
Fregona, D.7
Dou, Q.P.8
-
48
-
-
0037036523
-
Concentrations of Fe, Cu and Zn in breast tissue: A synchrotron XRF study
-
Geraki, K.; Farquharson, M.J.; Bradley, D.A. Concentrations of Fe, Cu and Zn in breast tissue: a synchrotron XRF study. Physics in medicine and biology, 2002, 47, 2327-2339.
-
(2002)
Physics In Medicine and Biology
, vol.47
, pp. 2327-2339
-
-
Geraki, K.1
Farquharson, M.J.2
Bradley, D.A.3
-
49
-
-
0019202882
-
Endothelial cell phagokinesis in response to specific metal ions
-
McAuslan, B.R.; Reilly, W. Endothelial cell phagokinesis in response to specific metal ions. Experimental cell research, 1980, 130, 147-157.
-
(1980)
Experimental Cell Research
, vol.130
, pp. 147-157
-
-
McAuslan, B.R.1
Reilly, W.2
-
50
-
-
33847213199
-
Rat epigastric flap survival and VEGF expression after local copper application
-
Frangoulis, M.; Georgiou, P.; Chrisostomidis, C.; Perrea, D.; Dontas, I.; Kavantzas, N.; Kostakis, A.; Papadopoulos, O. Rat epigastric flap survival and VEGF expression after local copper application. Plastic and reconstructive surgery, 2007, 119, 837-843.
-
(2007)
Plastic and Reconstructive Surgery
, vol.119
, pp. 837-843
-
-
Frangoulis, M.1
Georgiou, P.2
Chrisostomidis, C.3
Perrea, D.4
Dontas, I.5
Kavantzas, N.6
Kostakis, A.7
Papadopoulos, O.8
-
51
-
-
0036088085
-
Copper-induced vascular endothelial growth factor expression and wound healing
-
Sen, C.K.; Khanna, S.; Venojarvi, M.; Trikha, P.; Ellison, E.C.; Hunt, T.K.; Roy, S. Copper-induced vascular endothelial growth factor expression and wound healing. American journal of physiology. Heart and circulatory physiology, 2002, 282, H1821-1827.
-
(2002)
American journal of physiology. Heart and Circulatory Physiology
, vol.282
, pp. 1821-1827
-
-
Sen, C.K.1
Khanna, S.2
Venojarvi, M.3
Trikha, P.4
Ellison, E.C.5
Hunt, T.K.6
Roy, S.7
-
52
-
-
0036733754
-
Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis
-
Pan, Q.; Kleer, C.G.; van Golen, K.L.; Irani, J.; Bottema, K.M.; Bias, C.; De Carvalho, M.; Mesri, E.A.; Robins, D.M.; Dick, R.D.; Brewer, G.J.; Merajver, S.D. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer research, 2002, 62, 4854-4859.
-
(2002)
Cancer Research
, vol.62
, pp. 4854-4859
-
-
Pan, Q.1
Kleer, C.G.2
van Golen, K.L.3
Irani, J.4
Bottema, K.M.5
Bias, C.6
de Carvalho, M.7
Mesri, E.A.8
Robins, D.M.9
Dick, R.D.10
Brewer, G.J.11
Merajver, S.D.12
-
53
-
-
0035892359
-
The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells
-
Yoshii, J.; Yoshiji, H.; Kuriyama, S.; Ikenaka, Y.; Noguchi, R.; Okuda, H.; Tsujinoue, H.; Nakatani, T.; Kishida, H.; Nakae, D.; Gomez, D.E.; De Lorenzo, M.S.; Tejera, A.M.; Fukui, H. The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells. International journal of cancer. Journal international du cancer, 2001, 94, 768-773.
-
(2001)
International journal of cancer. Journal International Du Cancer
, vol.94
, pp. 768-773
-
-
Yoshii, J.1
Yoshiji, H.2
Kuriyama, S.3
Ikenaka, Y.4
Noguchi, R.5
Okuda, H.6
Tsujinoue, H.7
Nakatani, T.8
Kishida, H.9
Nakae, D.10
Gomez, D.E.11
de Lorenzo, M.S.12
Tejera, A.M.13
Fukui, H.14
-
54
-
-
0022590971
-
Zinc in human malignancies
-
Chakravarty, P.K.; Ghosh, A.; Chowdhury, J.R. Zinc in human malignancies. Neoplasma, 1986, 33, 85-90.
-
(1986)
Neoplasma
, vol.33
, pp. 85-90
-
-
Chakravarty, P.K.1
Ghosh, A.2
Chowdhury, J.R.3
-
55
-
-
0020589944
-
Copper and zinc levels in normal and malignant tissues
-
Margalioth, E.J.; Schenker, J.G.; Chevion, M. Copper and zinc levels in normal and malignant tissues. Cancer, 1983, 52, 868-872.
-
(1983)
Cancer
, vol.52
, pp. 868-872
-
-
Margalioth, E.J.1
Schenker, J.G.2
Chevion, M.3
-
56
-
-
0016137826
-
Trace elements in noraml and malignant human breast tissue
-
Schwartz, A.E.; Leddicotte, G.W.; Fink, R.W.; Friedman, E.W. Trace elements in noraml and malignant human breast tissue. Surgery, 1974, 76, 325-329.
-
(1974)
Surgery
, vol.76
, pp. 325-329
-
-
Schwartz, A.E.1
Leddicotte, G.W.2
Fink, R.W.3
Friedman, E.W.4
-
57
-
-
0029911793
-
The yeast ZRT1 gene encodes the zinc transporter protein of a high-affinity uptake system induced by zinc limitation
-
Zhao, H.; Eide, D. The yeast ZRT1 gene encodes the zinc transporter protein of a high-affinity uptake system induced by zinc limitation. Proceedings of the National Academy of Sciences of the United States of America, 1996, 93, 2454-2458.
-
(1996)
Proceedings of the National Academy of Sciences of the United States of America
, vol.93
, pp. 2454-2458
-
-
Zhao, H.1
Eide, D.2
-
58
-
-
36749037264
-
Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression
-
Li, M.; Zhang, Y.; Liu, Z.; Bharadwaj, U.; Wang, H.; Wang, X.; Zhang, S.; Liuzzi, J.P.; Chang, S.M.; Cousins, R.J.; Fisher, W.E.; Brunicardi, F.C.; Logsdon, C.D.; Chen, C.; Yao, Q. Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. Proceedings of the National Academy of Sciences of the United States of America, 2007, 104, 18636-18641.
-
(2007)
Proceedings of the National Academy of Sciences of the United States of America
, vol.104
, pp. 18636-18641
-
-
Li, M.1
Zhang, Y.2
Liu, Z.3
Bharadwaj, U.4
Wang, H.5
Wang, X.6
Zhang, S.7
Liuzzi, J.P.8
Chang, S.M.9
Cousins, R.J.10
Fisher, W.E.11
Brunicardi, F.C.12
Logsdon, C.D.13
Chen, C.14
Yao, Q.15
-
59
-
-
33745512125
-
The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: Connecting the dots
-
Costello, L.C.; Franklin, R.B. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Molecular cancer, 2006, 5, 17.
-
(2006)
Molecular Cancer
, vol.5
, pp. 17
-
-
Costello, L.C.1
Franklin, R.B.2
-
60
-
-
0028360127
-
Oestrogen-regulated genes in breast cancer: Association of pLIV1 with lymph node involvement
-
Manning, D.L.; Robertson, J.F.; Ellis, I.O.; Elston, C.W.; McClelland, R.A.; Gee, J.M.; Jones, R.J.; Green, C.D.; Cannon, P.; Blamey, R.W.; et al. Oestrogen-regulated genes in breast cancer: association of pLIV1 with lymph node involvement. Eur J Cancer, 1994, 30A, 675-678.
-
(1994)
Eur J Cancer
, vol.30 A
, pp. 675-678
-
-
Manning, D.L.1
Robertson, J.F.2
Ellis, I.O.3
Elston, C.W.4
McClelland, R.A.5
Gee, J.M.6
Jones, R.J.7
Green, C.D.8
Cannon, P.9
Blamey, R.W.10
-
61
-
-
34548488005
-
The emerging role of the LIV-1 subfamily of zinc transporters in breast cancer
-
Taylor, K.M.; Morgan, H.E.; Smart, K.; Zahari, N.M.; Pumford, S.; Ellis, I.O.; Robertson, J.F.; Nicholson, R.I. The emerging role of the LIV-1 subfamily of zinc transporters in breast cancer. Mol Med, 2007, 13, 396-406.
-
(2007)
Mol Med
, vol.13
, pp. 396-406
-
-
Taylor, K.M.1
Morgan, H.E.2
Smart, K.3
Zahari, N.M.4
Pumford, S.5
Ellis, I.O.6
Robertson, J.F.7
Nicholson, R.I.8
-
62
-
-
0028819948
-
Dose-dependent opposite effect of zinc on apoptosis in mouse thymocytes
-
Provinciali, M.; Di Stefano, G.; Fabris, N. Dose-dependent opposite effect of zinc on apoptosis in mouse thymocytes. International journal of immunopharmacology, 1995, 17, 735-744.
-
(1995)
International Journal of Immunopharmacology
, vol.17
, pp. 735-744
-
-
Provinciali, M.1
Di Stefano, G.2
Fabris, N.3
-
63
-
-
49749124150
-
Intracellular zinc homeostasis and zinc signaling
-
Murakami, M.; Hirano, T. Intracellular zinc homeostasis and zinc signaling. Cancer science, 2008, 99, 1515-1522.
-
(2008)
Cancer Science
, vol.99
, pp. 1515-1522
-
-
Murakami, M.1
Hirano, T.2
-
64
-
-
0035060404
-
Effects of selenium and zinc supplementation on nutritional status in patients with cancer of digestive tract
-
Federico, A.; Iodice, P.; Federico, P.; Del Rio, A.; Mellone, M.C.; Catalano, G. Effects of selenium and zinc supplementation on nutritional status in patients with cancer of digestive tract. European journal of clinical nutrition, 2001, 55, 293-297.
-
(2001)
European Journal of Clinical Nutrition
, vol.55
, pp. 293-297
-
-
Federico, A.1
Iodice, P.2
Federico, P.3
Del Rio, A.4
Mellone, M.C.5
Catalano, G.6
-
65
-
-
0031695113
-
Nutritional and zinc status of head and neck cancer patients: An interpretive review
-
Prasad, A.S.; Beck, F.W.; Doerr, T.D.; Shamsa, F.H.; Penny, H.S.; Marks, S.C.; Kaplan, J.; Kucuk, O.; Mathog, R.H. Nutritional and zinc status of head and neck cancer patients: an interpretive review. Journal of the American College of Nutrition, 1998, 17, 409-418.
-
(1998)
Journal of the American College of Nutrition
, vol.17
, pp. 409-418
-
-
Prasad, A.S.1
Beck, F.W.2
Doerr, T.D.3
Shamsa, F.H.4
Penny, H.S.5
Marks, S.C.6
Kaplan, J.7
Kucuk, O.8
Mathog, R.H.9
-
67
-
-
54549114503
-
Ni(II), Cu(II), and Zn(II) diethyldithiocarbamate complexes show various activities against the proteasome in breast cancer cells
-
Cvek, B.; Milacic, V.; Taraba, J.; Dou, Q.P. Ni(II), Cu(II), and Zn(II) diethyldithiocarbamate complexes show various activities against the proteasome in breast cancer cells. Journal of medicinal chemistry, 2008, 51, 6256-6258.
-
(2008)
Journal of Medicinal Chemistry
, vol.51
, pp. 6256-6258
-
-
Cvek, B.1
Milacic, V.2
Taraba, J.3
Dou, Q.P.4
-
68
-
-
0026439016
-
A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites. Acta psychiatrica Scandinavica
-
Johansson, B. A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites. Acta psychiatrica Scandinavica. Supplementum, 1992, 369, 15-26.
-
(1992)
Supplementum
, vol.369
, pp. 15-26
-
-
Johansson, B.1
-
69
-
-
0020033519
-
Human aldehyde dehydrogenase: Mechanism of inhibition of disulfiram
-
Vallari, R.C.; Pietruszko, R. Human aldehyde dehydrogenase: mechanism of inhibition of disulfiram. Science, 1982, 216, 637-639.
-
(1982)
Science
, vol.216
, pp. 637-639
-
-
Vallari, R.C.1
Pietruszko, R.2
-
70
-
-
0024426368
-
Prospects for a rational pharmacotherapy of alcoholism
-
Meyer, R.E. Prospects for a rational pharmacotherapy of alcoholism. The Journal of clinical psychiatry, 1989, 50, 403-412.
-
(1989)
The Journal of Clinical Psychiatry
, vol.50
, pp. 403-412
-
-
Meyer, R.E.1
-
71
-
-
11144224746
-
Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells
-
Cen, D.; Brayton, D.; Shahandeh, B.; Meyskens, F.L., Jr.; Farmer, P.J. Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells. Journal of medicinal chemistry, 2004, 47, 6914-6920.
-
(2004)
Journal of Medicinal Chemistry
, vol.47
, pp. 6914-6920
-
-
Cen, D.1
Brayton, D.2
Shahandeh, B.3
Meyskens Jr., F.L.4
Farmer, P.J.5
-
72
-
-
33751285781
-
Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity
-
Chen, D.; Cui, Q.C.; Yang, H.; Dou, Q.P. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Cancer research, 2006, 66, 10425-10433.
-
(2006)
Cancer Research
, vol.66
, pp. 10425-10433
-
-
Chen, D.1
Cui, Q.C.2
Yang, H.3
Dou, Q.P.4
-
73
-
-
4644235752
-
Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a metaldependent manner in vitro, in mice and in a patient with metastatic disease
-
Brar, S.S.; Grigg, C.; Wilson, K.S.; Holder, W.D., Jr.; Dreau, D.; Austin, C.; Foster, M.; Ghio, A.J.; Whorton, A.R.; Stowell, G.W.; Whittall, L.B.; Whittle, R.R.; White, D.P.; Kennedy, T.P. Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a metaldependent manner in vitro, in mice and in a patient with metastatic disease. Molecular cancer therapeutics, 2004, 3, 1049-1060.
-
(2004)
Molecular Cancer Therapeutics
, vol.3
, pp. 1049-1060
-
-
Brar, S.S.1
Grigg, C.2
Wilson, K.S.3
Holder Jr., W.D.4
Dreau, D.5
Austin, C.6
Foster, M.7
Ghio, A.J.8
Whorton, A.R.9
Stowell, G.W.10
Whittall, L.B.11
Whittle, R.R.12
White, D.P.13
Kennedy, T.P.14
-
74
-
-
0036050582
-
Disulfiram induces apoptosis in human melanoma cells: A redox-related process
-
Cen, D.; Gonzalez, R.I.; Buckmeier, J.A.; Kahlon, R.S.; Tohidian, N.B.; Meyskens, F.L., Jr. Disulfiram induces apoptosis in human melanoma cells: a redox-related process. Molecular cancer therapeutics, 2002, 1, 197-204.
-
(2002)
Molecular Cancer Therapeutics
, vol.1
, pp. 197-204
-
-
Cen, D.1
Gonzalez, R.I.2
Buckmeier, J.A.3
Kahlon, R.S.4
Tohidian, N.B.5
Meyskens Jr., F.L.6
-
75
-
-
0031825806
-
Dithiocarbamate toxicity toward thymocytes involves their copper-catalyzed conversion to thiuram disulfides, which oxidize glutathione in a redox cycle without the release of reactive oxygen species
-
Burkitt, M.J.; Bishop, H.S.; Milne, L.; Tsang, S.Y.; Provan, G.J.; Nobel, C.S.; Orrenius, S.; Slater, A.F. Dithiocarbamate toxicity toward thymocytes involves their copper-catalyzed conversion to thiuram disulfides, which oxidize glutathione in a redox cycle without the release of reactive oxygen species. Archives of biochemistry and biophysics, 1998, 353, 73-84.
-
(1998)
Archives of Biochemistry and Biophysics
, vol.353
, pp. 73-84
-
-
Burkitt, M.J.1
Bishop, H.S.2
Milne, L.3
Tsang, S.Y.4
Provan, G.J.5
Nobel, C.S.6
Orrenius, S.7
Slater, A.F.8
-
76
-
-
0033824372
-
Death signaling pathway induced by pyrrolidine dithiocarbamate- Cu(2+) complex in the cultured rat cortical astrocytes
-
Chen, S.H.; Liu, S.H.; Liang, Y.C.; Lin, J.K.; Lin-Shiau, S.Y. Death signaling pathway induced by pyrrolidine dithiocarbamate- Cu(2+) complex in the cultured rat cortical astrocytes. Glia, 2000, 31, 249-261.
-
(2000)
Glia
, vol.31
, pp. 249-261
-
-
Chen, S.H.1
Liu, S.H.2
Liang, Y.C.3
Lin, J.K.4
Lin-Shiau, S.Y.5
-
77
-
-
21344440550
-
Inhibition of prostate cancer cellular proteasome activity by a pyrrolidine dithiocarbamate-copper complex is associated with suppression of proliferation and induction of apoptosis
-
Chen, D.; Peng, F.; Cui, Q.C.; Daniel, K.G.; Orlu, S.; Liu, J.; Dou, Q.P. Inhibition of prostate cancer cellular proteasome activity by a pyrrolidine dithiocarbamate-copper complex is associated with suppression of proliferation and induction of apoptosis. Frontiers in bioscience: a journal and virtual library, 2005, 10, 2932-2939.
-
(2005)
Frontiers In Bioscience: A Journal and Virtual Library
, vol.10
, pp. 2932-2939
-
-
Chen, D.1
Peng, F.2
Cui, Q.C.3
Daniel, K.G.4
Orlu, S.5
Liu, J.6
Dou, Q.P.7
-
78
-
-
36549088961
-
Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis
-
Chen, J.; Du, C.; Kang, J.; Wang, J. Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis. Chemico-biological interactions, 2008, 171, 26-36.
-
(2008)
Chemico-biological Interactions
, vol.171
, pp. 26-36
-
-
Chen, J.1
Du, C.2
Kang, J.3
Wang, J.4
-
79
-
-
0036132060
-
Cu/Zn superoxide dismutase plays a role in angiogenesis
-
Marikovsky, M.; Nevo, N.; Vadai, E.; Harris-Cerruti, C. Cu/Zn superoxide dismutase plays a role in angiogenesis. International journal of cancer. Journal international du cancer, 2002, 97, 34-41.
-
(2002)
International journal of cancer. Journal International Du Cancer
, vol.97
, pp. 34-41
-
-
Marikovsky, M.1
Nevo, N.2
Vadai, E.3
Harris-Cerruti, C.4
-
80
-
-
35848955428
-
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
-
Ginestier, C.; Hur, M.H.; Charafe-Jauffret, E.; Monville, F.; Dutcher, J.; Brown, M.; Jacquemier, J.; Viens, P.; Kleer, C.G.; Liu, S.; Schott, A.; Hayes, D.; Birnbaum, D.; Wicha, M.S.; Dontu, G. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell, 2007, 1, 555-567.
-
(2007)
Cell Stem Cell
, vol.1
, pp. 555-567
-
-
Ginestier, C.1
Hur, M.H.2
Charafe-Jauffret, E.3
Monville, F.4
Dutcher, J.5
Brown, M.6
Jacquemier, J.7
Viens, P.8
Kleer, C.G.9
Liu, S.10
Schott, A.11
Hayes, D.12
Birnbaum, D.13
Wicha, M.S.14
Dontu, G.15
-
81
-
-
79955805229
-
Disulfiram modulated ROS-MAPK and NFkappaB pathways and targeted breast cancer cells with cancer stem cell-like properties
-
Yip, N.C.; Fombon, I.S.; Liu, P.; Brown, S.; Kannappan, V.; Armesilla, A.L.; Xu, B.; Cassidy, J.; Darling, J.L.; Wang, W. Disulfiram modulated ROS-MAPK and NFkappaB pathways and targeted breast cancer cells with cancer stem cell-like properties. British journal of cancer, 2011, 104, 1564-1574.
-
(2011)
British Journal of Cancer
, vol.104
, pp. 1564-1574
-
-
Yip, N.C.1
Fombon, I.S.2
Liu, P.3
Brown, S.4
Kannappan, V.5
Armesilla, A.L.6
Xu, B.7
Cassidy, J.8
Darling, J.L.9
Wang, W.10
-
82
-
-
0019955319
-
Modification of the sensitivity and repair of potentially lethal damage by diethyldithiocarbamate during and following exposure of plateau-phase cultures of mammalian cells to radiation and cisdiamminedichloroplatinum(II)
-
Evans, R.G.; Engel, C.; Wheatley, C.; Nielsen, J. Modification of the sensitivity and repair of potentially lethal damage by diethyldithiocarbamate during and following exposure of plateau-phase cultures of mammalian cells to radiation and cisdiamminedichloroplatinum(II). Cancer research, 1982, 42, 3074-3078.
-
(1982)
Cancer Research
, vol.42
, pp. 3074-3078
-
-
Evans, R.G.1
Engel, C.2
Wheatley, C.3
Nielsen, J.4
-
83
-
-
0020420511
-
Effect of disulfiram (tetraethylthiuram disulfide) amd diethyldithiocarbamate on the bladder toxicity and antitumor activity of cyclophosphamide in mice
-
Hacker, M.P.; Ershler, W.B.; Newman, R.A.; Gamelli, R.L. Effect of disulfiram (tetraethylthiuram disulfide) amd diethyldithiocarbamate on the bladder toxicity and antitumor activity of cyclophosphamide in mice. Cancer research, 1982, 42, 4490-4494.
-
(1982)
Cancer Research
, vol.42
, pp. 4490-4494
-
-
Hacker, M.P.1
Ershler, W.B.2
Newman, R.A.3
Gamelli, R.L.4
-
84
-
-
0022508021
-
Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate
-
Bodenner, D.L.; Dedon, P.C.; Keng, P.C.; Katz, J.C.; Borch, R.F. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate. Cancer research, 1986, 46, 2751-2755.
-
(1986)
Cancer Research
, vol.46
, pp. 2751-2755
-
-
Bodenner, D.L.1
Dedon, P.C.2
Keng, P.C.3
Katz, J.C.4
Borch, R.F.5
-
85
-
-
79251473704
-
Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth
-
Lin, J.; Haffner, M.C.; Zhang, Y.; Lee, B.H.; Brennen, W.N.; Britton, J.; Kachhap, S.K.; Shim, J.S.; Liu, J.O.; Nelson, W.G.; Yegnasubramanian, S.; Carducci, M.A. Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth. The Prostate, 2011, 71, 333-343.
-
(2011)
The Prostate
, vol.71
, pp. 333-343
-
-
Lin, J.1
Haffner, M.C.2
Zhang, Y.3
Lee, B.H.4
Brennen, W.N.5
Britton, J.6
Kachhap, S.K.7
Shim, J.S.8
Liu, J.O.9
Nelson, W.G.10
Yegnasubramanian, S.11
Carducci, M.A.12
-
86
-
-
77950581975
-
Exploring the structural requirements for inhibition of the ubiquitin E3 ligase breast cancer associated protein 2 (BCA2) as a treatment for breast cancer
-
Brahemi, G.; Kona, F.R.; Fiasella, A.; Buac, D.; Soukupova, J.; Brancale, A.; Burger, A.M.; Westwell, A.D. Exploring the structural requirements for inhibition of the ubiquitin E3 ligase breast cancer associated protein 2 (BCA2) as a treatment for breast cancer. Journal of medicinal chemistry, 2010, 53, 2757-2765.
-
(2010)
Journal of Medicinal Chemistry
, vol.53
, pp. 2757-2765
-
-
Brahemi, G.1
Kona, F.R.2
Fiasella, A.3
Buac, D.4
Soukupova, J.5
Brancale, A.6
Burger, A.M.7
Westwell, A.D.8
-
87
-
-
33644549964
-
Inhibition of proteasome activity, nuclear factor- KappaB translocation and cell survival by the antialcoholism drug disulfiram
-
Lovborg, H.; Oberg, F.; Rickardson, L.; Gullbo, J.; Nygren, P.; Larsson, R. Inhibition of proteasome activity, nuclear factor- KappaB translocation and cell survival by the antialcoholism drug disulfiram. International journal of cancer. Journal international du cancer, 2006, 118, 1577-1580.
-
(2006)
International journal of cancer. Journal International Du Cancer
, vol.118
, pp. 1577-1580
-
-
Lovborg, H.1
Oberg, F.2
Rickardson, L.3
Gullbo, J.4
Nygren, P.5
Larsson, R.6
-
88
-
-
33845304732
-
Pharmacological profiling of disulfiram using human tumor cell lines and human tumor cells from patients
-
Wickstrom, M.; Danielsson, K.; Rickardson, L.; Gullbo, J.; Nygren, P.; Isaksson, A.; Larsson, R.; Lovborg, H. Pharmacological profiling of disulfiram using human tumor cell lines and human tumor cells from patients. Biochemical pharmacology, 2007, 73, 25-33.
-
(2007)
Biochemical Pharmacology
, vol.73
, pp. 25-33
-
-
Wickstrom, M.1
Danielsson, K.2
Rickardson, L.3
Gullbo, J.4
Nygren, P.5
Isaksson, A.6
Larsson, R.7
Lovborg, H.8
-
90
-
-
0026590541
-
Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells
-
Schreck, R.; Meier, B.; Mannel, D.N.; Droge, W.; Baeuerle, P.A. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. The Journal of experimental medicine, 1992, 175, 1181-1194.
-
(1992)
The Journal of Experimental Medicine
, vol.175
, pp. 1181-1194
-
-
Schreck, R.1
Meier, B.2
Mannel, D.N.3
Droge, W.4
Baeuerle, P.A.5
-
91
-
-
33749143836
-
Inhibition of nuclear factor-kappaB by an antioxidant enhances paclitaxel sensitivity in ovarian carcinoma cell line
-
Liu, G.H.; Wang, S.R.; Wang, B.; Kong, B.H. Inhibition of nuclear factor-kappaB by an antioxidant enhances paclitaxel sensitivity in ovarian carcinoma cell line. International journal of gynecological cancer: official journal of the International Gynecological Cancer Society, 2006, 16, 1777-1782.
-
(2006)
International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society
, vol.16
, pp. 1777-1782
-
-
Liu, G.H.1
Wang, S.R.2
Wang, B.3
Kong, B.H.4
-
92
-
-
0032101138
-
Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells
-
Chinery, R.; Beauchamp, R.D.; Shyr, Y.; Kirkland, S.C.; Coffey, R.J.; Morrow, J.D. Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells. Cancer research, 1998, 58, 2323-2327.
-
(1998)
Cancer Research
, vol.58
, pp. 2323-2327
-
-
Chinery, R.1
Beauchamp, R.D.2
Shyr, Y.3
Kirkland, S.C.4
Coffey, R.J.5
Morrow, J.D.6
-
93
-
-
10744225520
-
HTLV-I Tax protein inhibits apoptosis induction but not G1 arrest by pyrrolidinedithiocarbamate, an antioxidant, in adult T cell leukemia cells
-
Arima, N.; Arimura, K.; Tokito, Y.; Sakaki, Y.; Matsushita, K.; Orihara, K.; Akimoto, M.; Ozaki, A.; Kukita, T.; Hagiwara, T.; Hamada, H.; Tei, C. HTLV-I Tax protein inhibits apoptosis induction but not G1 arrest by pyrrolidinedithiocarbamate, an antioxidant, in adult T cell leukemia cells. Experimental hematology, 2004, 32, 195-201.
-
(2004)
Experimental Hematology
, vol.32
, pp. 195-201
-
-
Arima, N.1
Arimura, K.2
Tokito, Y.3
Sakaki, Y.4
Matsushita, K.5
Orihara, K.6
Akimoto, M.7
Ozaki, A.8
Kukita, T.9
Hagiwara, T.10
Hamada, H.11
Tei, C.12
-
94
-
-
20844436142
-
Effect of NF-kappaB constitutive activation on proliferation and apoptosis of gastric cancer cell lines. European surgical research. Europaische chirurgische Forschung
-
Li, Q.; Yu, Y.Y.; Zhu, Z.G.; Ji, Y.B.; Zhang, Y.; Liu, B.Y.; Chen, X.H.; Lin, Y.Z. Effect of NF-kappaB constitutive activation on proliferation and apoptosis of gastric cancer cell lines. European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 2005, 37, 105-110.
-
(2005)
Recherches Chirurgicales Europeennes
, vol.37
, pp. 105-110
-
-
Li, Q.1
Yu, Y.Y.2
Zhu, Z.G.3
Ji, Y.B.4
Zhang, Y.5
Liu, B.Y.6
Chen, X.H.7
Lin, Y.Z.8
-
95
-
-
33751441045
-
-
Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association
-
Morais, C.; Pat, B.; Gobe, G.; Johnson, D.W.; Healy, H. Pyrrolidine dithiocarbamate exerts anti-proliferative and proapoptotic effects in renal cell carcinoma cell lines. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, 21, 3377-3388.
-
(2006)
Pyrrolidine Dithiocarbamate Exerts Anti-proliferative and Proapoptotic Effects In Renal Cell Carcinoma Cell Lines
, vol.21
, pp. 3377-3388
-
-
Morais, C.1
Pat, B.2
Gobe, G.3
Johnson, D.W.4
Healy, H.5
-
96
-
-
84901648175
-
Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells
-
Daniel, K.G.; Chen, D.; Orlu, S.; Cui, Q.C.; Miller, F.R.; Dou, Q.P. Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells. Breast Cancer Res, 2005, 7, R897-908.
-
(2005)
Breast Cancer Res
, vol.7
, pp. 897-908
-
-
Daniel, K.G.1
Chen, D.2
Orlu, S.3
Cui, Q.C.4
Miller, F.R.5
Dou, Q.P.6
-
97
-
-
33846211525
-
Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer
-
Hussain, S.A.; Ganesan, R.; Reynolds, G.; Gross, L.; Stevens, A.; Pastorek, J.; Murray, P.G.; Perunovic, B.; Anwar, M.S.; Billingham, L.; James, N.D.; Spooner, D.; Poole, C.J.; Rea, D.W.; Palmer, D.H. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. British journal of cancer, 2007, 96, 104-109.
-
(2007)
British Journal of Cancer
, vol.96
, pp. 104-109
-
-
Hussain, S.A.1
Ganesan, R.2
Reynolds, G.3
Gross, L.4
Stevens, A.5
Pastorek, J.6
Murray, P.G.7
Perunovic, B.8
Anwar, M.S.9
Billingham, L.10
James, N.D.11
Spooner, D.12
Poole, C.J.13
Rea, D.W.14
Palmer, D.H.15
-
98
-
-
84857420193
-
Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo
-
Carta, F.; Aggarwal, M.; Maresca, A.; Scozzafava, A.; McKenna, R.; Masini, E.; Supuran, C.T. Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo. Journal of medicinal chemistry, 2012.
-
(2012)
Journal of Medicinal Chemistry
-
-
Carta, F.1
Aggarwal, M.2
Maresca, A.3
Scozzafava, A.4
McKenna, R.5
Masini, E.6
Supuran, C.T.7
-
99
-
-
28544431575
-
A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer
-
Burger, A.M.; Gao, Y.; Amemiya, Y.; Kahn, H.J.; Kitching, R.; Yang, Y.; Sun, P.; Narod, S.A.; Hanna, W.M.; Seth, A.K. A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer. Cancer research, 2005, 65, 10401-10412.
-
(2005)
Cancer Research
, vol.65
, pp. 10401-10412
-
-
Burger, A.M.1
Gao, Y.2
Amemiya, Y.3
Kahn, H.J.4
Kitching, R.5
Yang, Y.6
Sun, P.7
Narod, S.A.8
Hanna, W.M.9
Seth, A.K.10
-
100
-
-
66149153421
-
Oral administration of pyrrolidine dithiocarbamate (PDTC) inhibits VEGF expression, tumor angiogenesis and growth of breast cancer in female mice
-
Gu, J.W.; Young, E.; Busby, B.; Covington, J.; Tan, W.; Johnson, J.W. Oral administration of pyrrolidine dithiocarbamate (PDTC) inhibits VEGF expression, tumor angiogenesis and growth of breast cancer in female mice. Cancer biology & therapy, 2009, 8.
-
(2009)
Cancer Biology & Therapy
, pp. 8
-
-
Gu, J.W.1
Young, E.2
Busby, B.3
Covington, J.4
Tan, W.5
Johnson, J.W.6
-
101
-
-
34249781706
-
Copper-binding compounds as proteasome inhibitors and apoptosis inducers in human cancer
-
Daniel, K.G.; Chen, D.; Yan, B.; Dou, Q.P. Copper-binding compounds as proteasome inhibitors and apoptosis inducers in human cancer. Frontiers in bioscience: a journal and virtual library, 2007, 12, 135-144.
-
(2007)
Frontiers In Bioscience: A Journal and Virtual Library
, vol.12
, pp. 135-144
-
-
Daniel, K.G.1
Chen, D.2
Yan, B.3
Dou, Q.P.4
|